by Dr. Yashashwini Reddy | Sep 26, 2025
📌 Case Study: Ranbaxy Laboratories – Data Falsification & GMP Violations Background:Ranbaxy Laboratories, once India’s largest generic drug manufacturer, faced one of the biggest regulatory scandals in the pharmaceutical industry. In 2013, the company admitted to...
by Dr. Yashashwini Reddy | Sep 24, 2025
Case Study: Ranbaxy & Glass Particles Recall (2014) Background:In 2014, Ranbaxy Laboratories recalled several batches of injectable products in the United States due to the presence of glass particles in vials. The recall was classified as a Class II recall by the...
